Concepedia

Publication | Open Access

Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women

DOIFull Paper Access

163

Citations

22

References

2010

Year

Andrea Z. LaCroix, TJ Powles, C. Kent Osborne, K. Wolter, John R. Thompson, David D. Thompson, D. Craig Allred, Roy A. Armstrong, S. R. Cummings, Richard Eastell,
JNCI Journal of the National Cancer Institute

Abstract

A 0.5-mg dose of lasofoxifene appears to reduce the risks of both total and ER+ invasive breast cancer in postmenopausal women with osteoporosis.

References

YearCitations

Page 1